Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

Phase 2

Recruiting

Conditions: Bladder Cancer
FGFR3 Gene Mutation
Recurrent Bladder Cancer

Interventions: Drug: Erdafitinib

First Posted Date: 2021-06-08

Last Posted Date: 2024-12-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT04917809

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors

Phase 2

Active, not recruiting

Conditions: Cancer
Remission

Interventions: Drug: Tibetree Pain Relieving Plaster
Other: Placebo

First Posted Date: 2021-06-07

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 68

Registration Number: NCT04916249

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 4 locations

A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer

Phase 2

Active, not recruiting

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Canakinumab
Drug: Durvalumab
Radiation: Radiation therapy
Drug: Chemotherapy

First Posted Date: 2021-05-27

Last Posted Date: 2024-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 41

Registration Number: NCT04905316

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 4 locations

A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

Phase 1

Recruiting

Conditions: Malignant Pleural Mesothelioma

Interventions: Drug: Pembrolizumab
Radiation: IMPRINT

First Posted Date: 2021-05-21

Last Posted Date: 2024-06-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT04897022

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Novel Imaging Technique to Assess Gynecologic Cancer

Phase 1

Recruiting

Conditions: Gynecologic Cancer

Interventions: Drug: Gadobutrol
Diagnostic Test: MRI

First Posted Date: 2021-05-19

Last Posted Date: 2024-01-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 70

Registration Number: NCT04893434

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Phase 2

Recruiting

Conditions: Intrahepatic Cholangiocarcinoma

Interventions: Drug: Gemcitabine
Drug: Oxaliplatin
Drug: Dexamethasone
Drug: Floxuridine (FUDR)
Device: Implanted Medical Device

First Posted Date: 2021-05-18

Last Posted Date: 2024-06-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 164

Registration Number: NCT04891289

Locations: 🇺🇸
National Heart, Lung, and Blood Institute (NIH) (Data Collection Only), Bethesda, Maryland, United States
🇺🇸
Washington University (Data Collection Only), Saint Louis, Missouri, United States
🇺🇸
Memorial Sloan Kettering Monmouth - Limited Protocol Activities, Middletown, New Jersey, United States

and more 7 locations

A Study of Attention and Memory Processes in Breast Cancer Survivors

Active, not recruiting

Conditions: Breast Cancer Survivors

First Posted Date: 2021-05-12

Last Posted Date: 2024-07-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 65

Registration Number: NCT04883398

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of a New Technique for Imaging Pancreatic Cancer

Phase 1

Active, not recruiting

Conditions: Tumors That Express CA19-9
Pancreatic Cancer

Interventions: Drug: MVT-2163
Drug: MVT-5873

First Posted Date: 2021-05-12

Last Posted Date: 2024-07-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4

Registration Number: NCT04883775

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack (Consent Only), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent only), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 4 locations

Stool Transplant to Control Treatment-related Diarrhea

Phase 1

Active, not recruiting

Conditions: Fecal Microbiota Transplantation (FMT)

Interventions: Biological: Fecal Microbiota Transplantation (FMT)

First Posted Date: 2021-05-12

Last Posted Date: 2024-10-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4

Registration Number: NCT04883762

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Intra-operative Imaging in Women With Ovarian Cancer

Phase 3

Recruiting

Conditions: Ovarian Cancer
Ovarian Carcinoma

Interventions: Diagnostic Test: Intravenous Indocyanine Green/ICG injection
Diagnostic Test: PINPOINT endoscopic fluorescence imaging system
Diagnostic Test: Endoscopy

First Posted Date: 2021-05-07

Last Posted Date: 2024-11-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 310

Registration Number: NCT04878094

Locations: 🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

and more 5 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy